![Amy Schacterle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Schacterle
General Counsel at
ACUMEN PHARMACEUTICALS, INC.
Net worth: 246 449 $ as of 2026-06-29
Profile
Presently, Amy Schacterle occupies the position of Senior VP-Research & Development Strategy at SAGE Therapeutics, Inc. In her past career Dr. Schacterle was Vice President-Regulatory Affairs at Sunovion Pharmaceuticals, Inc. She received an undergraduate degree from Rensselaer Polytechnic Institute and a doctorate and a graduate degree from the University of Virginia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-15 | 92,303 ( 0.13% ) | 246 449 $ | 2026-06-29 |
Amy Schacterle active positions
| Companies | Position | Start |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | General Counsel | 2024-11-05 |
Former positions of Amy Schacterle
| Companies | Position | End |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-12-31 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | General Counsel | 2013-12-31 |
Training of Amy Schacterle
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
- Stock Market
- Insiders
- Amy Schacterle
Choose MarketScreener 
